SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-030835
Filing Date
2019-02-07
Accepted
2019-02-07 16:01:30
Documents
57
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d656704d10q.htm 10-Q 342761
2 EX-3.1 d656704dex31.htm EX-3.1 26675
3 EX-10.1 d656704dex101.htm EX-10.1 421688
4 EX-31.1 d656704dex311.htm EX-31.1 10481
5 EX-31.2 d656704dex312.htm EX-31.2 10466
6 EX-32.1 d656704dex321.htm EX-32.1 5187
13 GRAPHIC g6567041.jpg GRAPHIC 11637
14 GRAPHIC g6567042.jpg GRAPHIC 10761
15 GRAPHIC g6567043.jpg GRAPHIC 5089
16 GRAPHIC g656704g62x41.jpg GRAPHIC 38191
  Complete submission text file 0001193125-19-030835.txt   4336184

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT meip-20181231.xml EX-101.INS 947179
8 XBRL TAXONOMY EXTENSION SCHEMA meip-20181231.xsd EX-101.SCH 33690
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20181231_cal.xml EX-101.CAL 25905
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20181231_def.xml EX-101.DEF 234134
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20181231_lab.xml EX-101.LAB 292751
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20181231_pre.xml EX-101.PRE 256963
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 19575162
SIC: 2834 Pharmaceutical Preparations